Advanced Search
XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
Citation: XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
shu

Advances of new antidiabetic drugs

More Information
    Graphical Abstract
    • Abstract
  • Diabetes mellitus,an epidemic metabolic disorder characterized by high blood glucose level associated with various microvascular complications,is one of the main causes of human suffering across the globe.With the advance of the pathogenesis of diabetic research,the study of anti-diabetic drugs has transformed from the traditional drugs to the current products with new targets and new mechanism.Some of these drugs are already marketed or still in clinical trials,e.g. GLP-1 activator,DPP-4 inhibitor,GPR119 activator,SGLT-2 inhibitor,11β-HSD1 inhibitor,PTP1B inhibitor and so on.In this article,the new antidiabetic drugs mentioned above are reviewed with regard to the therapeutic targets and mechanism.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]TANG Qian, CHEN Song, GAO Xiangdong. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 622-628. DOI: 10.11665/j.issn.1000-5048.20170519
    [2]SI Lianghui, MA Hui, ZHOU Jinpei, ZHANG Huibin. Advances in antidiabetic small molecule ABHD6 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 125-134. DOI: 10.11665/j.issn.1000-5048.20170201
    [3]MO Xianwei, ZHANG Lei, GUAN Su, YAN Jinwu, LI Jing. Advances in antidepressants based on the regulation of serotonin receptors[J]. Journal of China Pharmaceutical University, 2016, 47(6): 639-647. DOI: 10.11665/j.issn.1000-5048.20160602
    [4]ZHU Kuiniu, WU Zhengfeng, JIANG Cuihua, CAO Lanjie, ZHANG Jian, YIN Zhiqi. Advances on hypoglycemic activity and mechanism of triterpenoids[J]. Journal of China Pharmaceutical University, 2015, 46(6): 764-770. DOI: 10.11665/j.issn.1000-5048.20150622
    [5]CHEN Qingyu, ZHOU Jianping, HUO Meirong. Advances in the nanotechnology-based drug delivery systems of silymarin[J]. Journal of China Pharmaceutical University, 2015, 46(3): 376-384. DOI: 10.11665/j.issn.1000-5048.20150320
    [6]WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202
    [7]WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303
    [8]ZHANG Shengmiao, SUN Haopeng, JIA Jianmin, XU Xiaoli, YOU Qidong. Advances on indenoisoquinoline compounds with antitumor activities[J]. Journal of China Pharmaceutical University, 2013, 44(6): 589-595. DOI: 10.11665/j.issn.1000-5048.20130620
    [9]LIU Jinchuan, PENG Guizi, LU Zhijun, ZUO Lian. Advances of recombinant human follicle-stimulating hormone[J]. Journal of China Pharmaceutical University, 2013, 44(3): 283-288. DOI: 10.11665/j.issn.1000-5048.20130319
    [10]WANG Jing, ZHANG Hui-bin, ZHOU Jin-pei, LI Qing. Advances in new anti-tuberculosis targets and related drugs[J]. Journal of China Pharmaceutical University, 2012, 43(1): 1-8.

Catalog

    Get Citation
    PDF
    XML
    Article views (6689) PDF downloads (9202) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：435781

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return